Relaxin-2 vs Vasostatin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Relaxin-2 (H2 Relaxin) is an endogenous peptide hormone of the insulin superfamily, best known for its roles in pregnancy physiology including cervical ripening, uterine quiescence, and connective tissue remodeling. Beyond reproduction, relaxin-2 is a systemic anti-fibrotic and v...
Calculate Relaxin-2 dose →Vasostatin refers to the N-terminal fragments of chromogranin A (CgA), particularly CgA1-76 (Vasostatin-1) and CgA1-113 (Vasostatin-2), generated by proteolytic processing of the chromogranin A precursor. While catestatin (CgA352-372) is the C-terminal CgA fragment with anti-cate...
Calculate Vasostatin dose →| Parameter | Relaxin-2 | Vasostatin |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Clinical | Preclinical Research |
| Half-Life | 10-15 min (plasma) | ~20-30 minutes (estimated) |
| Typical Dose | 30-300 mcg/kg/day (IV) | 0.1-10 nmol/kg IV (animal) |
| Frequency | Continuous 48-hour infusion (trials) | Acute dosing |
| Route | Intravenous (infusion) | IV (research) |
| FDA Status | Not approved (Phase III completed) | Research compound |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.